Scholar IQ
Try ScholarIQ free
Upload Records Snowball Search Search OpenAlex
About the database
On this page:OverviewPublicationsResearchersInstitutionsOpen access
ScholarIQanswers from OpenAlex

Kishiwada City Hospital

InstitutionResearch output, impact & collaborations

Kishiwada City Hospital is a research organisation in Osaka, JP. OpenAlex records 1,033 works and 33,341 citations for it. 273 researchers list it as their most recent affiliation.

1,033
Works
33,341
Citations
273
Researchers
13.5
Avg h-index

How has Kishiwada City Hospital's publication output changed over time?

ScholarIQpublication output · 1989–2020

Output grew0% over the shown period — from 1 works in 1989 to 1 in 2020.

1
2
2
1
3
2
1
1989201120152016201820192020

Who are the most-cited researchers behind Kishiwada City Hospital?

ScholarIQtop researchers by citations
1
Satomi Watanabe · HER2/EGFR in Cancer Research
133 works888 citations
2
Soichi Fumita · Gastrointestinal motility and disorders
41 works832 citations

What are the most-cited papers on Kishiwada City Hospital?

ScholarIQmost cited works
Safety and efficacy of nivolumab in combination with S-1/capecitabine plus oxaliplatin in patients with previously untreated, unresectable, advanced, or recurrent gastric/gastroesophageal junction cancer: interim results of a randomized, phase II trial (ATTRACTION-4)
Narikazu Boku, Min‐Hee Ryu, Ken Kato, Hyun Cheol Chung, Keiko Minashi, K.-W. Lee, H. Cho, Won Ki Kang, Yoshito Komatsu, Masahiro Tsuda, Kensei Yamaguchi, Hiroki Hara, Soichi Fumita, Mizutomo Azuma, L.-T. Chen, Yoon‐Koo Kang
Annals of Oncology. 2018325 CitationsOPEN ACCESS
An HER3-targeting antibody–drug conjugate incorporating a DNA topoisomerase I inhibitor U3-1402 conquers EGFR tyrosine kinase inhibitor-resistant NSCLC
Kimio Yonesaka, Naoki Takegawa, Satomi Watanabe, Koji Haratani, Hisato Kawakami, Kazuko Sakai, Yasutaka Chiba, Naoyuki Maeda, Takashi Kagari, Kenji Hirotani, Kazuto Nishio, Kazuhiko Nakagawa
S128439998. 2018102 Citations
Clinical Application of the FoundationOne CDx Assay to Therapeutic Decision-Making for Patients with Advanced Solid Tumors
Masayuki Takeda, Takayuki Takahama, Kazuko Sakai, Shigeki Shimizu, Satomi Watanabe, Hisato Kawakami, Kaoru Tanaka, Chihiro Sato, Hidetoshi Hayashi, Yoshikane Nonagase, Kimio Yonesaka, Naoki Takegawa, Tatsuya Okuno, Takeshi Yoshida, Soichi Fumita, Shinichiro Suzuki, Koji Haratani, Kazumasa Saigoh, Akihiko Ito, Tetsuya Mitsudomi, Hisashi Handa, Kazuya Fukuoka, Kazuhiko Nakagawa, Kazuto Nishio
The Oncologist. 202097 CitationsOPEN ACCESS
Targeting of the HER2/HER3 signaling axis overcomes ligand‐mediated resistance to trastuzumab in HER2‐positive breast cancer
Satomi Watanabe, Kimio Yonesaka, Junko Tanizaki, Yoshikane Nonagase, Naoki Takegawa, Koji Haratani, Hisato Kawakami, Hidetoshi Hayashi, Masayuki Takeda, Junji Tsurutani, Kazuhiko Nakagawa
Cancer Medicine. 201975 CitationsOPEN ACCESS
HER2 genomic amplification in circulating tumor DNA from patients with cetuximab-resistant colorectal cancer
Naoki Takegawa, Kimio Yonesaka, Kazuko Sakai, Hiroto Ueda, Satomi Watanabe, Yoshikane Nonagase, Tatsuya Okuno, Masayuki Takeda, Osamu Maenishi, Junji Tsurutani, Taroh Satoh, Isamu Okamoto, Kazuto Nishio, Takao Tamura, Kazuhiko Nakagawa
Oncotarget. 201570 CitationsOPEN ACCESS

How much of the research on Kishiwada City Hospital is open access?

ScholarIQopen access share
58%OPEN ACCESS
Gold
33%
Green
0%
Hybrid
8%
Bronze
17%
Closed
42%

Related on ScholarIQ

Lung Cancer Treatments and Mutations
Top Topic
Heart Failure Treatment and Management
Top Topic
Cardiovascular Function and Risk Factors
Top Topic
Cancer Immunotherapy and Biomarkers
Top Topic
Cardiac Valve Diseases and Treatments
Top Topic
Shoulder Injury and Treatment
Top Topic
470M+ articles · free account